TradingKey

关于 Penumbra Inc 公司

Penumbra, Inc. 是一家医疗保健公司。该公司设计、开发、制造和销售产品，并拥有一系列产品，可解决市场上尚未满足需求的棘手医疗状况。该公司专注于开发、制造和销售供专科医生和医疗保健提供者使用的产品，以推动改善临床和健康结果。该公司专注于开发和构建其产品组合，包括血栓切除术、栓塞术、通路和沉浸式医疗保健技术。该公司关注的常见疾病包括肺栓塞、深静脉血栓形成、外周动脉闭塞、缺血性中风、急性冠状动脉综合征、与动静脉移植或瘘相关的血栓、动脉瘤和出血性中风。该公司主要通过其在美国、欧洲、加拿大和澳大利亚的直销组织以及在特定国际市场的分销商向医疗保健提供者销售其产品。

公司简介

公司代码PEN

公司名称Penumbra Inc

上市日期Sep 18, 2015

成立日期2004

CEOMr. Adam Elsesser, J.D.

员工数量4500

证券类型Ordinary Share

年结日Sep 18

公司地址One Penumbra Place

城市ALAMEDA

上市交易所NYSE Consolidated

国家United States of America

邮编94502

电话15109952486

网址https://www.penumbrainc.com/

公司代码PEN

上市日期Sep 18, 2015

成立日期2004

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Adam Elsesser, J.D.

Chairman of the Board, President, Chief Executive Officer

983.84K

+2.48%

Dr. Arani Bose, M.D.

Director

302.26K

-3.82%

Ms. Johanna Roberts

Executive Vice President, General Counsel, Secretary

53.48K

-1.11%

Mr. Lambert Shiu

Chief Accounting Officer

25.61K

-4.98%

Ms. Janet Leeds

Independent Director

5.49K

-1.06%

Ms. Bridget O'Rourke

Independent Director

4.82K

-1.03%

Ms. Surbhi Sarna

Independent Director

3.15K

-1.84%

Ms. Maggie S. Yuen

Chief Financial Officer

--

Mr. Thomas C. (Tom) Wilder, III

Presiding Independent Director

--

Mr. Harpreet S. Grewal

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Adam Elsesser, J.D.

Chairman of the Board, President, Chief Executive Officer

983.84K

+2.48%

Dr. Arani Bose, M.D.

Director

302.26K

-3.82%

Ms. Johanna Roberts

Executive Vice President, General Counsel, Secretary

53.48K

-1.11%

Mr. Lambert Shiu

Chief Accounting Officer

25.61K

-4.98%

Ms. Janet Leeds

Independent Director

5.49K

-1.06%

Ms. Bridget O'Rourke

Independent Director

4.82K

-1.03%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Thrombectomy

226.54M

69.89%

Embolization and Access

97.60M

30.11%

地区USD

名称

营收

占比

United States

256.86M

79.24%

International

67.28M

20.76%

业务

地区

业务USD

名称

营收

占比

Thrombectomy

226.54M

69.89%

Embolization and Access

97.60M

30.11%

股东统计

更新时间: 7月23日周三

持股股东

股东类型

持股股东

占比

Fidelity Management & Research Company LLC

12.68%

The Vanguard Group, Inc.

9.40%

BlackRock Institutional Trust Company, N.A.

9.04%

State Street Global Advisors (US)

3.07%

T. Rowe Price Associates, Inc.

3.02%

Other

62.79%

持股股东

占比

Fidelity Management & Research Company LLC

12.68%

The Vanguard Group, Inc.

9.40%

BlackRock Institutional Trust Company, N.A.

9.04%

State Street Global Advisors (US)

3.07%

T. Rowe Price Associates, Inc.

3.02%

Other

62.79%

股东类型

持股股东

占比

Investment Advisor

59.67%

Investment Advisor/Hedge Fund

20.88%

Hedge Fund

6.73%

Individual Investor

3.63%

Pension Fund

1.71%

Research Firm

1.47%

Sovereign Wealth Fund

0.63%

Bank and Trust

0.52%

Venture Capital

0.17%

Other

4.57%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

851

36.96M

94.78%

-3.09M

2025Q1

878

36.92M

95.33%

-3.44M

2024Q4

834

37.02M

96.10%

-3.78M

2024Q3

813

37.33M

96.12%

-2.93M

2024Q2

796

37.57M

96.93%

+395.13K

2024Q1

777

35.67M

92.18%

-2.09M

2023Q4

759

36.33M

94.13%

-67.98K

2023Q3

737

35.15M

91.46%

-2.09M

2023Q2

719

36.20M

94.64%

-1.94M

2023Q1

681

37.31M

97.62%

-964.82K

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Fidelity Management & Research Company LLC

4.95M

12.77%

+91.48K

+1.88%

Mar 31, 2025

The Vanguard Group, Inc.

3.67M

9.47%

+24.73K

+0.68%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.53M

9.11%

+30.07K

+0.86%

Mar 31, 2025

State Street Global Advisors (US)

1.20M

3.09%

-5.56K

-0.46%

Mar 31, 2025

T. Rowe Price Associates, Inc.

1.18M

3.04%

-58.36K

-4.73%

Mar 31, 2025

Elsesser (Adam)

960.02K

2.48%

+24.15K

+2.58%

Jun 25, 2025

Fidelity Institutional Asset Management

894.92K

2.31%

-70.23K

-7.28%

Mar 31, 2025

Champlain Investment Partners, LLC

869.92K

2.25%

-626.03K

-41.85%

Mar 31, 2025

RTW Investments L.P.

862.77K

2.23%

+320.00

+0.04%

Mar 31, 2025

Citadel Advisors LLC

784.31K

2.03%

+50.02K

+6.81%

Mar 31, 2025

持股ETF

更新时间: 7月6日周日

机构名称

占比

Motley Fool Small-Cap Growth ETF

3.5%

First Trust Health Care Alphadex Fund

2.07%

Congress SMid Growth ETF

1.9%

First Trust Indxx Medical Devices ETF

1.84%

ROBO Global Healthcare Technology & Innovation ETF

1.84%

SPDR S&P Health Care Equipment ETF

1.83%

Tema Neuroscience and Mental Health ETF

1.62%

Putnam Sustainable Future ETF

1.61%

iShares U.S. Medical Devices ETF

1.12%

ProShares Metaverse ETF

1.08%

Motley Fool Small-Cap Growth ETF

占比3.5%

First Trust Health Care Alphadex Fund

占比2.07%

Congress SMid Growth ETF

占比1.9%

First Trust Indxx Medical Devices ETF

占比1.84%

ROBO Global Healthcare Technology & Innovation ETF

占比1.84%

SPDR S&P Health Care Equipment ETF

占比1.83%

Tema Neuroscience and Mental Health ETF

占比1.62%

Putnam Sustainable Future ETF

占比1.61%

iShares U.S. Medical Devices ETF

占比1.12%

ProShares Metaverse ETF

占比1.08%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Penumbra Inc

241.830USD

Penumbra Inc

241.830

概览

公司

财务